Westerveld H - Search Results

1

Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.

Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, Petrič P, Mahantshetty U, Dörr W, Pötter R. Kirchheiner K, et al. Among authors: westerveld h. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):88-95. doi: 10.1016/j.ijrobp.2014.01.032. Int J Radiat Oncol Biol Phys. 2014. PMID: 24725693

2

Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.

Westerveld H, Pötter R, Berger D, Dankulchai P, Dörr W, Sora MC, Pötter-Lang S, Kirisits C. Westerveld H, et al. Radiother Oncol. 2013 Apr;107(1):99-105. doi: 10.1016/j.radonc.2013.04.009. Epub 2013 Apr 29. Radiother Oncol. 2013. PMID: 23639578 Free article.

3

Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer.

Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Westerveld H, Jürgenliemk-Schulz IM. Nomden CN, et al. Among authors: westerveld h. Radiother Oncol. 2014 Aug;112(2):217-20. doi: 10.1016/j.radonc.2014.08.010. Epub 2014 Sep 10. Radiother Oncol. 2014. PMID: 25216574

4

Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.

Westerveld H, de Leeuw A, Kirchheiner K, Dankulchai P, Oosterveld B, Oinam A, Hudej R, Swamidas J, Lindegaard J, Tanderup K, Pötter R, Kirisits C; EMBRACE Collaborative Group. Westerveld H, et al. Radiother Oncol. 2016 Sep;120(3):420-427. doi: 10.1016/j.radonc.2016.05.002. Epub 2016 May 26. Radiother Oncol. 2016. PMID: 27237058

5

Optimal Patient Positioning (Prone Versus Supine) for VMAT in Gynecologic Cancer: A Dosimetric Study on the Effect of Different Margins.

Heijkoop ST, Westerveld H, Bijker N, Feije R, Sharfo AW, van Wieringen N, Mens JWM, Stalpers LJA, Hoogeman MS. Heijkoop ST, et al. Among authors: westerveld h. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):432-439. doi: 10.1016/j.ijrobp.2016.05.025. Epub 2016 Jun 8. Int J Radiat Oncol Biol Phys. 2016. PMID: 27598808

6

Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.

de Boer P, Jürgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, Dávila-Fajardo R, Rasch CRN, Pieters BR, Stalpers LJA. de Boer P, et al. Among authors: westerveld h. Radiother Oncol. 2017 May;123(2):306-311. doi: 10.1016/j.radonc.2017.04.005. Epub 2017 Apr 20. Radiother Oncol. 2017. PMID: 28434797

7

Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.

Derks M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, Westerveld H, van der Velden J, Kenter GG. Derks M, et al. Among authors: westerveld h. Int J Gynecol Cancer. 2017 Jun;27(5):1015-1020. doi: 10.1097/IGC.0000000000000974. Int J Gynecol Cancer. 2017. PMID: 28498252

8

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.

Wortman BG, Bosse T, Nout RA, Lutgens LCHW, van der Steen-Banasik EM, Westerveld H, van den Berg H, Slot A, De Winter KAJ, Verhoeven-Adema KW, Smit VTHBM, Creutzberg CL; PORTEC Study Group. Wortman BG, et al. Among authors: westerveld h. Gynecol Oncol. 2018 Oct;151(1):69-75. doi: 10.1016/j.ygyno.2018.07.020. Epub 2018 Aug 3. Gynecol Oncol. 2018. PMID: 30078506 Free article. Clinical Trial.

9

Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.

Schmid MP, Fokdal L, Westerveld H, Chargari C, Rohl L, Morice P, Nesvacil N, Mazeron R, Haie-Meder C, Pötter R, Nout RA; GEC-ESTRO GYN Working Group. Schmid MP, et al. Among authors: westerveld h. Radiother Oncol. 2020 Apr;145:36-44. doi: 10.1016/j.radonc.2019.11.005. Epub 2019 Dec 23. Radiother Oncol. 2020. PMID: 31874348

10

Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer.

Westerveld H, Nesvacil N, Fokdal L, Chargari C, Schmid MP, Milosevic M, Mahantshetty UM, Nout RA. Westerveld H, et al. Lancet Oncol. 2020 Mar;21(3):e157-e167. doi: 10.1016/S1470-2045(19)30855-1. Lancet Oncol. 2020. PMID: 32135119 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters